HSBC Holdings
EXAS

HSBC Holdings’s Exact Sciences EXAS Stock Holding History

HSBC Holdings’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-201,576
Closed -$20.5M – 3008
2025
Q4 		$20.5M Sell
201,576
-162,094
-45% -$13M 0.01% 739
2025
Q3 		$19.9M Buy
363,670
+16,493
+5% +$824K 0.01% 722
2025
Q2 		$18.4M Sell
347,177
-1,062
-0.3% -$54K 0.01% 729
2025
Q1 		$15.1M Buy
348,239
+6,137
+2% +$311K 0.01% 791
2024
Q4 		$19.2M Buy
342,102
+66,942
+24% +$4.17M 0.01% 743
2024
Q3 		$18.7M Buy
275,160
+190,942
+227% +$10.8M 0.01% 742
2024
Q2 		$3.57M Sell
84,218
-108,342
-56% -$5.96M ﹤0.01% 1179
2024
Q1 		$13.3M Buy
192,560
+117,556
+157% +$7.44M 0.01% 801
2023
Q4 		$5.56M Sell
75,004
-1,501
-2% -$98.4K ﹤0.01% 1111
2023
Q3 		$5.23M Sell
76,505
-28,663
-27% -$2.43M 0.01% 1066
2023
Q2 		$9.89M Buy
105,168
+52,925
+101% +$4.13M 0.01% 821
2023
Q1 		$3.54M Sell
52,243
-10,112
-16% -$650K ﹤0.01% 1259
2022
Q4 		$3.08M Sell
62,355
-44,805
-42% -$1.83M ﹤0.01% 1495
2022
Q3 		$3.53M Buy
107,160
+19,730
+23% +$813K 0.01% 1321
2022
Q2 		$3.48M Sell
87,430
-51,506
-37% -$2.75M ﹤0.01% 1336
2022
Q1 		$9.85M Buy
138,936
+71,056
+105% +$5.19M 0.01% 907
2021
Q4 		$5.29M Sell
67,880
-47
-0.1% -$4.15K ﹤0.01% 1230
2021
Q3 		$6.43M Buy
67,927
+16,566
+32% +$1.75M 0.01% 1050
2021
Q2 		$6.43M Buy
51,361
+13,665
+36% +$1.63M 0.01% 1006
2021
Q1 		$4.91M Sell
37,696
-2,096
-5% -$287K 0.01% 1025
2020
Q4 		$5.3M Buy
39,792
+10,271
+35% +$1.24M 0.01% 997
2020
Q3 		$3.02M Sell
29,521
-5,273
-15% -$455K ﹤0.01% 1140
2020
Q2 		$3.02M Sell
34,794
-25,093
-42% -$2M 0.01% 1037
2020
Q1 		$3.48M Buy
59,887
+4,081
+7% +$331K 0.01% 973
2019
Q4 		$5.16M Buy
55,806
+9,619
+21% +$846K 0.01% 1088
2019
Q3 		$4.17M Buy
46,187
+17,108
+59% +$1.95M 0.01% 1265
2019
Q2 		$3.43M Buy
29,079
+5,258
+22% +$530K 0.01% 1310
2019
Q1 		$2.06M Buy
23,821
+14,384
+152% +$1.22M ﹤0.01% 1496
2018
Q4 		$595K Sell
9,437
-3,308
-26% -$227K ﹤0.01% 2035
2018
Q3 		$1M Buy
12,745
+2,691
+27% +$175K ﹤0.01% 1742
2018
Q2 		$601K Buy
10,054
+2,910
+41% +$157K ﹤0.01% 1997
2018
Q1 		$288K Sell
7,144
-160
-2% -$7.8K ﹤0.01% 2206
2017
Q4 		$383K Sell
7,304
-30
-0.4% -$1.6K ﹤0.01% 1605
2017
Q3 		$345K Buy
7,334
+10
+0.1% +$403 ﹤0.01% 1884
2017
Q2 		$259K Buy
+7,324
New +$226K ﹤0.01% 1949
2017
Q1 		– Sell
-18,524
Closed -$247K – 2253
2016
Q4 		$247K Buy
+18,524
New +$299K ﹤0.01% 2384

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

HSBC Holdings's EXAS Position: Q1 2026 in Review

HSBC Holdings sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 201,576 shares — an estimated $20.5M sold.

HSBC Holdings first reported a position in EXAS in Q4 2016 and held it in 36 quarters. The position peaked at $20.5M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • HSBC Holdings reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • HSBC Holdings sold 201,576 Exact Sciences shares in Q1 2026, an estimated $20.5M.
  • HSBC Holdings first reported a position in Exact Sciences in Q4 2016 and held it in 36 quarters.
  • HSBC Holdings's Exact Sciences position peaked at $20.5M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.